ELIXA

Evaluation of Cardiovascular Outcomes in Patients With Type 2 Diabetes After Acute Coronary Syndrome During Treatment With AVE0010 (Lixisenatide)

Stage: klaar
Medicine: lixisenatide
Population: Diabetes Mellitus
Phase: III
First Patient In: 15 August 2010
Last Patient In: 31 July 2013
Last Patient Last Visit: -

Study Director

prof. dr. J.H. Cornel

Cardioloog